Shares of life sciences toolmaker Qiagen (NYSE:QGEN) have shown renewed momentum, gaining over 12% in the past month. This surge brings the company's valuation into sharp focus, with analysts divided between near-term earnings multiples and long-term cash flow projections.
From a record-breaking public health crisis in South Carolina to a stunning archaeological find in Mexico, here are the major developments you need to know this afternoon, alongside a look at how global politics is reshaping daily life from Havana to your local coffee shop.
A new Congressional Budget Office analysis reveals the substantial financial burden of deploying National Guard and active-duty troops to several U.S. cities last year, with monthly costs for continued operations running into the tens of millions.
In a fiery address to the U.S. Conference of Mayors, Minneapolis Mayor Jacob Frey called on local leaders nationwide to resist what he described as aggressive federal immigration enforcement, arguing such operations undermine public safety and constitutional rights.
Nissan Motor Co. faced a 4.4% decline in global sales for 2025, with a sharper 6.7% drop in December, as weakness in key markets like China and Europe offset gains in North America.
Marsh & McLennan's insurance brokerage giant Marsh reported a 4.2% rise in Q4 net income to $821 million, capping a year of robust growth and strategic brand realignment under the new 'Marsh Risk' banner.
Taiwan's economy surged 8.6% in 2025, its fastest growth since 2010, driven by a global AI boom and a landmark trade agreement with the United States. While analysts project a moderation in 2026, the island's pivotal role in the tech supply chain has delivered record profits for its leading firms.
BitMEX co-founder Arthur Hayes argues that Bitcoin's recent downturn is a symptom of a broader $300 billion contraction in U.S. dollar liquidity, driven by Treasury cash management and tighter financial conditions, rather than crypto-specific weakness.
The Institute of Chartered Accountants of Scotland launches its 2026 CA Rising Stars search, introducing a new 'Community and Social Value' award to recognize young professionals driving ethical and technological change in the field.
A nationwide investigation has revealed 517 illegal waste sites across England, some containing over 20,000 tonnes of material, raising urgent questions about the integrity of packaging waste management and corporate accountability.
While regional tensions and market volatility capture headlines, a closer look reveals resilient companies with strong fundamentals. Driven by robust earnings and strategic positioning, select stocks in sectors from renewable energy to infrastructure present compelling cases for value-oriented investors navigating the complex landscape of early 2026.
HSBC UK and Sage have unveiled 'My Business Finances', a new digital tool embedded within the bank's platform to help sole traders and landlords comply with upcoming Making Tax Digital (MTD) for Income Tax rules, streamlining invoicing, bookkeeping, and tax filing in one place.
The enterprise software giant reported a 19% jump in Q4 cloud revenue, with full-year net income more than doubling. CEO Christian Klein credits AI adoption and the 'RISE with SAP' program as key growth drivers for the coming years.
Official figures reveal a sharp 26% increase in the annual cost of public sector pensions, now reaching £39bn, with taxpayers covering the bulk of the expense as employer contribution rates rise.
The Horatio Alger Award bestowed upon ResMed founder Dr. Peter Farrell underscores the company's decades-long leadership in sleep and respiratory care, bringing its financial performance and competitive strategy into sharper focus for investors.
Blue Owl Capital faces a wave of securities class actions alleging disclosure failures around liquidity and redemptions, casting a shadow over its robust alternative asset management platform. As legal pressures mount, the market weighs solid analyst backing against growing governance concerns, setting the stage for a pivotal earnings report.
Biotech firm Argenx SE sees its flagship drug Vyvgart outperform sales expectations in myasthenia gravis and CIDP treatments, with analysts pointing to sustained growth and regulatory momentum as key drivers.
The long-standing pillar of UK e-commerce—free and unlimited returns—is facing a fundamental overhaul as soaring costs and changing consumer habits force retailers to adopt more targeted and sustainable policies.
Robert Half International reports a pivotal return to sequential revenue growth in Q4 2025, signaling a potential turning point after a prolonged slump. However, the staffing giant continues to grapple with significant year-over-year declines, highlighting an uneven recovery path for the broader professional labor market.
Parker-Hannifin posts record-breaking Q2 fiscal 2026 results, fueled by robust organic growth and margin expansion, particularly in aerospace. The industrial giant raises full-year guidance and details strategic progress on its planned acquisition of Filtration Group Corporation.
